메뉴 건너뛰기




Volumn 40, Issue 4, 2011, Pages 837-846

Hyperprolactinemia and infertility

Author keywords

Bromocriptine; Cabergoline; Infertility; Pituitary tumor; Prolactin

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; CONJUGATED ESTROGEN; DOPAMINE RECEPTOR STIMULATING AGENT; ORAL CONTRACEPTIVE AGENT; PROLACTIN; QUINAGOLIDE;

EID: 82855162737     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2011.08.008     Document Type: Review
Times cited : (34)

References (54)
  • 1
    • 77950475252 scopus 로고    scopus 로고
    • Prolactinomas
    • Klibanski A. Prolactinomas. N Engl J Med 2010, 362:1219-1226.
    • (2010) N Engl J Med , vol.362 , pp. 1219-1226
    • Klibanski, A.1
  • 2
    • 0023813607 scopus 로고
    • Effects of prolactin and estrogen deficiency in amenorrheic bone loss
    • Klibanski A., Biller B.M., Rosenthal D.I., et al. Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinol Metab 1988, 67:124-130.
    • (1988) J Clin Endocrinol Metab , vol.67 , pp. 124-130
    • Klibanski, A.1    Biller, B.M.2    Rosenthal, D.I.3
  • 3
    • 0026783954 scopus 로고
    • A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia
    • Schlechte J., Walker L., Kathol M. A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia. J Clin Endocrinol Metab 1992, 75:698-703.
    • (1992) J Clin Endocrinol Metab , vol.75 , pp. 698-703
    • Schlechte, J.1    Walker, L.2    Kathol, M.3
  • 4
    • 0019382626 scopus 로고
    • Hyperprolactinemia-a significant factor in female infertility
    • Kredentser J.V., Hoskins C.F., Scott J.Z. Hyperprolactinemia-a significant factor in female infertility. Am J Obstet Gynecol 1981, 139:264-267.
    • (1981) Am J Obstet Gynecol , vol.139 , pp. 264-267
    • Kredentser, J.V.1    Hoskins, C.F.2    Scott, J.Z.3
  • 5
    • 0021991283 scopus 로고
    • Menstrual pattern and ovarian function in women with hyperprolactinemia
    • Bahamondes L., Faundes A., Tambascia M., et al. Menstrual pattern and ovarian function in women with hyperprolactinemia. Int J Gynaecol Obstet 1985, 23:31-36.
    • (1985) Int J Gynaecol Obstet , vol.23 , pp. 31-36
    • Bahamondes, L.1    Faundes, A.2    Tambascia, M.3
  • 6
    • 0023201288 scopus 로고
    • Suppression of pulsatile LH secretion, pituitary GnRH receptor content and pituitary responsiveness to GnRH by hyperprolactinemia in the male rat
    • Fox S.R., Hoefer M.T., Bartke A., et al. Suppression of pulsatile LH secretion, pituitary GnRH receptor content and pituitary responsiveness to GnRH by hyperprolactinemia in the male rat. Neuroendocrinology 1987, 46:350-359.
    • (1987) Neuroendocrinology , vol.46 , pp. 350-359
    • Fox, S.R.1    Hoefer, M.T.2    Bartke, A.3
  • 7
    • 0021870960 scopus 로고
    • Hyperprolactinemia inhibits gonadotropin-releasing hormone (GnRH) stimulation of the number of pituitary GnRH receptors
    • Garcia A., Herbon L., Barkan A., et al. Hyperprolactinemia inhibits gonadotropin-releasing hormone (GnRH) stimulation of the number of pituitary GnRH receptors. Endocrinology 1985, 117:954-959.
    • (1985) Endocrinology , vol.117 , pp. 954-959
    • Garcia, A.1    Herbon, L.2    Barkan, A.3
  • 8
    • 0034101143 scopus 로고    scopus 로고
    • Abnormal LH pulsatility in women with hyperprolactinemic amenorrhea normalizes after bromocriptine treatment: deconvolution-based assessment
    • Sartorio A., Pizzocaro A., Liberati D., et al. Abnormal LH pulsatility in women with hyperprolactinemic amenorrhea normalizes after bromocriptine treatment: deconvolution-based assessment. Clin Endocrinol (Oxf) 2000, 52:703-712.
    • (2000) Clin Endocrinol (Oxf) , vol.52 , pp. 703-712
    • Sartorio, A.1    Pizzocaro, A.2    Liberati, D.3
  • 9
    • 0021159754 scopus 로고
    • Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: response to bromocriptine
    • Sauder S.E., Frager M., Case G.D., et al. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: response to bromocriptine. J Clin Endocrinol Metab 1984, 59:941-948.
    • (1984) J Clin Endocrinol Metab , vol.59 , pp. 941-948
    • Sauder, S.E.1    Frager, M.2    Case, G.D.3
  • 10
    • 0017647392 scopus 로고
    • Hypogonadism, galactorrhea and hyperprolactinemia: evaluation of pituitary gonadotrophins reserve before and under bromocriptine
    • Asfour M., L'Hermite M., Hedouin-Quincampoix M., et al. Hypogonadism, galactorrhea and hyperprolactinemia: evaluation of pituitary gonadotrophins reserve before and under bromocriptine. Acta Endocrinol (Copenh) 1977, 84:738-749.
    • (1977) Acta Endocrinol (Copenh) , vol.84 , pp. 738-749
    • Asfour, M.1    L'Hermite, M.2    Hedouin-Quincampoix, M.3
  • 11
    • 0015897591 scopus 로고
    • Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction
    • Mortimer C.H., Besser G.M., McNeilly A.S., et al. Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J 1973, 4:73-77.
    • (1973) Br Med J , vol.4 , pp. 73-77
    • Mortimer, C.H.1    Besser, G.M.2    McNeilly, A.S.3
  • 12
    • 0016550926 scopus 로고
    • Specific receptors for prolactin in the ovary
    • Saito T., Saxena B.B. Specific receptors for prolactin in the ovary. Acta Endocrinol (Copenh) 1975, 80:126-137.
    • (1975) Acta Endocrinol (Copenh) , vol.80 , pp. 126-137
    • Saito, T.1    Saxena, B.B.2
  • 13
    • 0016714087 scopus 로고
    • Demonstration of a specific receptor for prolactin in porcine granulosa cells
    • Rolland R., Hammond J.M. Demonstration of a specific receptor for prolactin in porcine granulosa cells. Endocr Res Commun 1975, 2:281-298.
    • (1975) Endocr Res Commun , vol.2 , pp. 281-298
    • Rolland, R.1    Hammond, J.M.2
  • 14
    • 0019830067 scopus 로고
    • Prolactin inhibits oestrogen synthesis in the ovary
    • Dorrington J., Gore-Langton R.E. Prolactin inhibits oestrogen synthesis in the ovary. Nature 1981, 290:600-602.
    • (1981) Nature , vol.290 , pp. 600-602
    • Dorrington, J.1    Gore-Langton, R.E.2
  • 15
    • 0020438109 scopus 로고
    • Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17β estradiol in the human ovary
    • Demura R., Ono M., Demura H., et al. Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17β estradiol in the human ovary. J Clin Endocrinol Metab 1982, 54:1246-1250.
    • (1982) J Clin Endocrinol Metab , vol.54 , pp. 1246-1250
    • Demura, R.1    Ono, M.2    Demura, H.3
  • 18
    • 0029095150 scopus 로고
    • Polycystic ovary syndrome
    • Franks S. Polycystic ovary syndrome. N Engl J Med 1995, 333:853-861.
    • (1995) N Engl J Med , vol.333 , pp. 853-861
    • Franks, S.1
  • 19
    • 0035201094 scopus 로고    scopus 로고
    • The surgical management of pituitary adenomas in a series of 3,093 patients
    • Jane J.A., Laws E.R. The surgical management of pituitary adenomas in a series of 3,093 patients. J Am Coll Surg 2001, 193:651-659.
    • (2001) J Am Coll Surg , vol.193 , pp. 651-659
    • Jane, J.A.1    Laws, E.R.2
  • 21
    • 0022501528 scopus 로고
    • Long-term follow-up of women with surgically treated prolactin-secreting pituitary tumors
    • Schlechte J.A., Sherman B.M., Chapler F.K., et al. Long-term follow-up of women with surgically treated prolactin-secreting pituitary tumors. J Clin Endocrinol Metab 1986, 62:1296-1301.
    • (1986) J Clin Endocrinol Metab , vol.62 , pp. 1296-1301
    • Schlechte, J.A.1    Sherman, B.M.2    Chapler, F.K.3
  • 22
    • 0036358612 scopus 로고    scopus 로고
    • Relapse of hyperprolactinemia after transsphenoidal surgery for microprolactinoma: lesions from long-term follow-up
    • Thompson J.A., Gray C.E., Teasdale G.M. Relapse of hyperprolactinemia after transsphenoidal surgery for microprolactinoma: lesions from long-term follow-up. Neurosurgery 2002, 50:36-40.
    • (2002) Neurosurgery , vol.50 , pp. 36-40
    • Thompson, J.A.1    Gray, C.E.2    Teasdale, G.M.3
  • 23
    • 0015608836 scopus 로고
    • Suppression of pituitary tumor growth and function by ergot alkaloids
    • MacLeod R.M., Lehmeyer J.E. Suppression of pituitary tumor growth and function by ergot alkaloids. Cancer Res 1973, 33:849-855.
    • (1973) Cancer Res , vol.33 , pp. 849-855
    • MacLeod, R.M.1    Lehmeyer, J.E.2
  • 24
    • 0036933895 scopus 로고    scopus 로고
    • Medical management of pituitary adenomas: structural and ultrastructural changes
    • Asa S.L., Ezzat S. Medical management of pituitary adenomas: structural and ultrastructural changes. Pituitary 2002, 5:133-139.
    • (2002) Pituitary , vol.5 , pp. 133-139
    • Asa, S.L.1    Ezzat, S.2
  • 25
    • 0021994564 scopus 로고
    • Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study
    • Molitch M.E., Elton R.L., Blackwell R.E., et al. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab 1985, 60:698-705.
    • (1985) J Clin Endocrinol Metab , vol.60 , pp. 698-705
    • Molitch, M.E.1    Elton, R.L.2    Blackwell, R.E.3
  • 26
    • 0026742206 scopus 로고
    • Dopamine agonists and pituitary tumor shrinkage
    • Bevan J.S., Webster J., Burke C.W., et al. Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 1992, 13:220-240.
    • (1992) Endocr Rev , vol.13 , pp. 220-240
    • Bevan, J.S.1    Webster, J.2    Burke, C.W.3
  • 27
    • 0028146981 scopus 로고
    • A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
    • Webster J., Piscitelli G., Polli A., et al. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med 1994, 331:904-909.
    • (1994) N Engl J Med , vol.331 , pp. 904-909
    • Webster, J.1    Piscitelli, G.2    Polli, A.3
  • 28
    • 0031017930 scopus 로고    scopus 로고
    • Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment
    • Colao A., Di Sarno A., Sarnacchiaro S., et al. Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. J Clin Endocrinol Metab 1997, 82:876-883.
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 876-883
    • Colao, A.1    Di Sarno, A.2    Sarnacchiaro, S.3
  • 29
    • 0029653901 scopus 로고
    • Cabergoline versus bromocriptine for hyperprolactinaemic amenorrhea. Results of a multicentric, randomized, double-blind trial in France
    • Pascal-Vigneron V., Weryha G., Bosc M., et al. Cabergoline versus bromocriptine for hyperprolactinaemic amenorrhea. Results of a multicentric, randomized, double-blind trial in France. Presse Med 1995, 24:753-757.
    • (1995) Presse Med , vol.24 , pp. 753-757
    • Pascal-Vigneron, V.1    Weryha, G.2    Bosc, M.3
  • 30
    • 0022521699 scopus 로고
    • Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine
    • Demont J.F., Rostin M., Dueymes J.M., et al. Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine. Clin Neuropharmacol 1986, 9:200-201.
    • (1986) Clin Neuropharmacol , vol.9 , pp. 200-201
    • Demont, J.F.1    Rostin, M.2    Dueymes, J.M.3
  • 31
    • 0023736795 scopus 로고
    • Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease
    • McElvaney N.G., Wilcox P.G., Churg A., et al. Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease. Arch Intern Med 1988, 148:2231-2236.
    • (1988) Arch Intern Med , vol.148 , pp. 2231-2236
    • McElvaney, N.G.1    Wilcox, P.G.2    Churg, A.3
  • 32
    • 33845974147 scopus 로고    scopus 로고
    • Valvular heart disease and the use of dopamine agonists for Parkinson's disease
    • Zanettini R., Antonini A., Gatto G., et al. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 2007, 356:39-46.
    • (2007) N Engl J Med , vol.356 , pp. 39-46
    • Zanettini, R.1    Antonini, A.2    Gatto, G.3
  • 33
    • 33845986031 scopus 로고    scopus 로고
    • Dopamine agonists and the risk of cardiac-valve regurgitation
    • Schade R., Andersohn F., Suissa S., et al. Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 2007, 356:29-38.
    • (2007) N Engl J Med , vol.356 , pp. 29-38
    • Schade, R.1    Andersohn, F.2    Suissa, S.3
  • 34
    • 63049114030 scopus 로고    scopus 로고
    • Cabergoline therapy and the risk of cardiac valve regurgitation in patients with hyperprolactinemia: a meta-analysis from clinical studies
    • Bogazzi F., Manetti L., Raffaelli V., et al. Cabergoline therapy and the risk of cardiac valve regurgitation in patients with hyperprolactinemia: a meta-analysis from clinical studies. J Endocrinol Invest 2008, 31:1119-1123.
    • (2008) J Endocrinol Invest , vol.31 , pp. 1119-1123
    • Bogazzi, F.1    Manetti, L.2    Raffaelli, V.3
  • 35
    • 77749234191 scopus 로고    scopus 로고
    • Potential cardiac valve effects of dopamine agonists in hyperprolactinemia
    • Valassi E., Klibanski A., Biller B.M. Potential cardiac valve effects of dopamine agonists in hyperprolactinemia. J Clin Endocrinol Metab 2010, 95:1025-1033.
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 1025-1033
    • Valassi, E.1    Klibanski, A.2    Biller, B.M.3
  • 36
    • 33644595738 scopus 로고    scopus 로고
    • Quinagolide-a valuable treatment option for hyperprolactinaemia
    • Barlier A., Jaquet P. Quinagolide-a valuable treatment option for hyperprolactinaemia. Eur J Endocrinol 2006, 154:187-195.
    • (2006) Eur J Endocrinol , vol.154 , pp. 187-195
    • Barlier, A.1    Jaquet, P.2
  • 37
    • 0029873353 scopus 로고    scopus 로고
    • A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation
    • Webster J. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation. Drug Saf 1996, 14:228-238.
    • (1996) Drug Saf , vol.14 , pp. 228-238
    • Webster, J.1
  • 38
    • 0023185499 scopus 로고
    • Bromocriptine in pregnancy: safety aspects
    • Krupp P., Monka C. Bromocriptine in pregnancy: safety aspects. Klin Wochenschr 1987, 65:823-827.
    • (1987) Klin Wochenschr , vol.65 , pp. 823-827
    • Krupp, P.1    Monka, C.2
  • 39
    • 33644870007 scopus 로고    scopus 로고
    • Prolactinomas and pregnancy
    • Bronstein M.D. Prolactinomas and pregnancy. Pituitary 2005, 8:31-38.
    • (2005) Pituitary , vol.8 , pp. 31-38
    • Bronstein, M.D.1
  • 40
    • 78049319324 scopus 로고    scopus 로고
    • Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature
    • Stalldecker G., Mallea-Gil M.S., Guitelman M., et al. Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature. Pituitary 2010, 13(4):345-350.
    • (2010) Pituitary , vol.13 , Issue.4 , pp. 345-350
    • Stalldecker, G.1    Mallea-Gil, M.S.2    Guitelman, M.3
  • 41
    • 77954508608 scopus 로고    scopus 로고
    • Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas
    • Ono M., Miki N., Amano K., et al. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J Clin Endocrinol Metab 2010, 95:2672-2679.
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 2672-2679
    • Ono, M.1    Miki, N.2    Amano, K.3
  • 42
    • 77954873663 scopus 로고    scopus 로고
    • Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinemic women
    • Lebbe M., Hubinont C., Bernard P., et al. Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinemic women. Clin Endocrinol 2010, 73:236-242.
    • (2010) Clin Endocrinol , vol.73 , pp. 236-242
    • Lebbe, M.1    Hubinont, C.2    Bernard, P.3
  • 43
    • 0242351840 scopus 로고    scopus 로고
    • Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity and the effects of hospital and surgeon volume
    • Barker F.G., Klibanski A., Swearingen B. Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 2003, 88:4709-4719.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 4709-4719
    • Barker, F.G.1    Klibanski, A.2    Swearingen, B.3
  • 44
    • 0031607891 scopus 로고    scopus 로고
    • Pituitary dimensions and volume measurements in pregnancy and post partum. MR assessment
    • Dinc H., Esen F., Demirci A., et al. Pituitary dimensions and volume measurements in pregnancy and post partum. MR assessment. Acta Radiol 1998, 39:64-69.
    • (1998) Acta Radiol , vol.39 , pp. 64-69
    • Dinc, H.1    Esen, F.2    Demirci, A.3
  • 45
    • 0021988079 scopus 로고
    • Pregnancy and the hyperprolactinemic woman
    • Molitch M.E. Pregnancy and the hyperprolactinemic woman. N Engl J Med 1985, 312:1364-1370.
    • (1985) N Engl J Med , vol.312 , pp. 1364-1370
    • Molitch, M.E.1
  • 46
    • 0020543027 scopus 로고
    • Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas
    • Konopka P., Raymond J.P., Merceron R.E., et al. Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas. Am J Obstet Gynecol 1983, 146:935-938.
    • (1983) Am J Obstet Gynecol , vol.146 , pp. 935-938
    • Konopka, P.1    Raymond, J.P.2    Merceron, R.E.3
  • 47
    • 0022639779 scopus 로고
    • The safety of bromocriptine in long-term use: a review of the literature
    • Weil C. The safety of bromocriptine in long-term use: a review of the literature. Curr Med Res Opin 1986, 10:25-51.
    • (1986) Curr Med Res Opin , vol.10 , pp. 25-51
    • Weil, C.1
  • 49
    • 0022497825 scopus 로고
    • Women with prolactinoma-effect of pregnancy and lactation on serum prolactin and on tumor growth
    • Holmgren U., Bergstrand G., Hagenfeldt K., et al. Women with prolactinoma-effect of pregnancy and lactation on serum prolactin and on tumor growth. Acta Endocrinol (Copenh) 1986, 111:452-459.
    • (1986) Acta Endocrinol (Copenh) , vol.111 , pp. 452-459
    • Holmgren, U.1    Bergstrand, G.2    Hagenfeldt, K.3
  • 50
    • 0029792717 scopus 로고    scopus 로고
    • Long-term follow-up of patients with hyperprolactinaemia
    • Jeffcoate W.J., Pound N., Sturrock N.D., et al. Long-term follow-up of patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 1996, 45:299-303.
    • (1996) Clin Endocrinol (Oxf) , vol.45 , pp. 299-303
    • Jeffcoate, W.J.1    Pound, N.2    Sturrock, N.D.3
  • 51
    • 0024545674 scopus 로고
    • The natural history of untreated hyperprolactinemia: a prospective analysis
    • Schlechte J., Dolan K., Sherman B., et al. The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab 1989, 68:412-418.
    • (1989) J Clin Endocrinol Metab , vol.68 , pp. 412-418
    • Schlechte, J.1    Dolan, K.2    Sherman, B.3
  • 52
    • 0026494897 scopus 로고
    • The effect of combined estrogen/progesterone treatment in women with hyperprolactinemic amenorrhea
    • Fathy U.M., Foster P.A., Torode H.W., et al. The effect of combined estrogen/progesterone treatment in women with hyperprolactinemic amenorrhea. Gynecol Endocrinol 1992, 6:183-188.
    • (1992) Gynecol Endocrinol , vol.6 , pp. 183-188
    • Fathy, U.M.1    Foster, P.A.2    Torode, H.W.3
  • 53
    • 0027462619 scopus 로고
    • The safety of physiological estrogen plus progestin replacement therapy with oral contraceptive therapy in women with pathological hyperprolactinemia
    • Corenblum B., Donovan L. The safety of physiological estrogen plus progestin replacement therapy with oral contraceptive therapy in women with pathological hyperprolactinemia. Fertil Steril 1993, 59:671-673.
    • (1993) Fertil Steril , vol.59 , pp. 671-673
    • Corenblum, B.1    Donovan, L.2
  • 54
    • 75149154619 scopus 로고    scopus 로고
    • Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systemic review and meta-analysis
    • Dekkers O.M., Lagro J., Burman P., et al. Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systemic review and meta-analysis. J Clin Endocrinol Metab 2010, 95:43-51.
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 43-51
    • Dekkers, O.M.1    Lagro, J.2    Burman, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.